Dna X(NASDAQ) SONM

Market Cap$5.05M

Since IPO (2019)-100%

5 Year-100%

1 Year-72%

1 Month-36%

$3.26

+4.82%

+0.15Today

After hours$3.37+$0.11 (+3.37%)

Dna X last closing stock price
Metric	Price	Date
Last close	USD 3.39	2026-07-31

Dna X stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+7.66%	USD 3.15	2026-07-24
1 month	-35.51%	USD 5.26	2026-07-01
3 month	-30.63%	USD 4.89	2026-05-01
Year to date	+7.68%	USD 3.15	2025-12-31
1 year	-71.58%	USD 11.94	2025-07-31
3 year	-98.12%	USD 180.72	2023-08-01
5 year	-99.54%	USD 742.50	2021-07-30
Since inception	-99.98%	USD 19,781.98	2019-05-10

Dna X Financials at a Glance

Market Cap

$5.05M

Revenue (TTM)

-$16.72M

Net Income (TTM)

-$14.78M

EPS (TTM)

-$177.67

P/E Ratio

-0.02

Dividend

$0.00

Beta (Volatility)

1.16 (Average)

Dividend

$0.00

Beta (Volatility)

1.16 (Average)

Price

$3.26

Volume

7,573.94

Open

$3.12

Price

$3.26

Volume

7,573.94

Open

$3.12

Previous Close

$3.39

Daily Range

$3.12 - $3.39

52-Week Range

$2.52 - $16.97

Estimated Earnings Date

Aug 17, 2026

Dividend

$0.00

Beta (Volatility)

1.16 (Average)

Price

$3.26

Volume

7,573.94

Open

$3.12

Previous Close

$3.39

Daily Range

$3.12 - $3.39

52-Week Range

$2.52 - $16.97

Estimated Earnings Date

Aug 17, 2026

SONM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dna X

DNA X helps people trade cryptocurrencies online without holding their assets. Its platform lets users buy, sell, and automate crypto trades. The service aims to make trading easier for individuals worldwide.

Products and Services

Crypto Trading Platform: Lets users trade, swap, and automate cryptocurrency transactions; 100% of 2025 revenue from continuing operations.
Automated Strategy Tools: Users can create, test, and share trading strategies with public leaderboards.
Simulation Features: Allows users to practice trades and view top-performing strategies before risking real assets.
Planned Crypto Lending: Developing features for users to lend or borrow crypto for interest-like fees.
Legacy Rugged Devices: Sold rugged phones and hotspots until January 2026; now discontinued.

Growth and Expansion

Acquired DNA X, LLC and launched crypto trading platform in December 2025.
Sold legacy phone and hotspot business for $15M in January 2026.
Shifted focus to crypto trading, ending hardware operations in early 2026.
Plans to expand platform features and supported cryptocurrencies in 2026.

What Makes DNA X Stand Out

DNA X does not hold customer crypto, reducing some risks. Its platform offers low trading fees and tools for automated strategies. The company relies on organic growth and aims to attract users with educational features.

Five Things You Need to Know

Revenue was $16M in QQ3 2025, up 7.9% from QQ3 2024.
Operating loss was $4M in QQ3 2025, down from $2M in QQ3 2024.
Cash used in operations was $7M in QQ3 2025, down from $417K in QQ3 2024.
Legacy business contributed $56.9M in 2025 revenue before being sold.

Bottom Line

DNA X has shifted from hardware to focus on crypto trading. The company faces liquidity and competition challenges as it builds its new business model.

AI Generated • Apr 16, 2026

Industry

Technology Hardware, Storage and Peripherals

Sector

Information Technology

Employees

160

CEO

Michael C. Mulica, MBA

Website

www.sonimtech.com

Headquarters

San Diego, CA 92121, US

SONM Financials

Key Financial Metrics (TTM)

Gross Margin

75.69%

Operating Margin

57.83%

Net Income Margin

88.36%

Return on Equity

668.17%

Return on Capital

N/A

Return on Assets

-305.39%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.05M

Shares Outstanding

1.49M

Volume

7.57K

Avg. Volume

25.68K

Financials (TTM)

Gross Profit

-$12.66M

Operating Income

-$9.67M

EBITDA

-$6.45M

Operating Cash Flow

-$17.39M

Capital Expenditure

$0.00

Free Cash Flow

-$17.39M

Cash & ST Invst.

$1.20M

Total Debt

$1.07M

Dna X Performance Analysis

Dna X annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 69,828,000	28.0%
2023	2023-12-31	USD 93,632,000	34.1%
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 0	N/A

Dna X sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-33.1%
Q3	2025-09-30	44.9%
Q4	2025-12-31	-372.1%
Q1	2026-03-31	100.0%

Dna X annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -87.77	-88.1%
2023	2023-12-31	USD -0.39	-99.6%
2024	2024-12-31	USD -128.37	32917.2%
2025	2025-12-31	USD -28.58	-77.7%

Dna X sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-1107.7%
Q3	2025-09-30	-511.4%
Q4	2025-12-31	85.9%
Q1	2026-03-31	-357.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$5.05M

N/A

Market Cap/Employee

$1.26M

N/A

Employees

N/A

Net Income

$6.34M

+1284.3%

EBITDA

-$2.54M

-246.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$1.20M

-43.5%

Total Debt

$1.07M

-62.1%

Accounts Receivable

$1.50M

-86.9%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.07M

-52.7%

Return on Assets

-3.05%

N/A

Return on Invested Capital

-18.70%

N/A

Free Cash Flow

-$3.47M

+63.9%

Operating Cash Flow

-$3.47M

+63.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SOSSOS Limited

SOSSOS Limited$0.92-3.97%

GXAIGaxos.ai Inc.

GXAIGaxos.ai Inc.$0.75-5.70%

CLROClearOne, Inc.

CLROClearOne, Inc.$4.08-5.34%

NVNINvni Group Limited Ordinary Shares

NVNINvni Group Limited Ordinary Shares$1.06+0.95%

BHATFujian Blue Hat Interactive Entertainment Technology Ltd.

BHATFujian Blue Hat Interactive Entertainment Technology Ltd.$0.68+349.70%

FIEEFiEE, Inc.

FIEEFiEE, Inc.$2.99-1.64%

WATTEnergous Corporation

WATTEnergous Corporation$14.11+0.57%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$200.75+0.03%

AAPLApple

AAPLApple$308.91-0.07%

AMZNAmazon

AMZNAmazon$271.58+0.15%

INTCIntel

INTCIntel$90.20-0.01%

FCUVFocus Universal

FCUVFocus Universal$11.60+5.17%

NOKNokia

NOKNokia$9.14+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.62+0.02%

Questions About SONM

What is the current price of Dna X?

Dna X is trading at $3.39 per share.

What is the 52-week range for Dna X?

Over the past 52 weeks, Dna X has traded between $2.52 and $16.97.

How much debt does Dna X have?

As of the most recent reporting period, Dna X reported total debt of $1.47M.

How much cash does Dna X have on hand?

Dna X reported $1.20M in cash and cash equivalents in its most recent financial results.

What is Dna X’s dividend yield?

Dna X does not currently have a dividend yield.

Dna X(NASDAQ) SONM

Dna X Financials at a Glance

SONM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Dna X

Products and Services

Growth and Expansion

What Makes DNA X Stand Out

Five Things You Need to Know

Bottom Line

SONM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Dna X Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SONM

What is the current price of Dna X?

What is the 52-week range for Dna X?

How much debt does Dna X have?

How much cash does Dna X have on hand?

What is Dna X’s dividend yield?

Premium Investing Services